Allergan Inc. Extends Expiration Date Of Inamed Corporation Exchange Offer

IRVINE, Calif.--(BUSINESS WIRE)--Feb. 6, 2006--Allergan, Inc. (NYSE:AGN) today announced that it is extending the expiration date of its exchange offer for all outstanding shares of common stock of Inamed Corporation (NASDAQ:IMDC). The exchange offer is being extended as U.S. antitrust approval of the Inamed acquisition has not yet been received, and will now expire at 5:00 p.m. Eastern Time on February 22, 2006. The exchange offer was previously scheduled to expire at 5:00 p.m. Eastern Time on Tuesday, February 7, 2006. Approximately 19,329,021 shares, or approximately 52.4%, of Inamed's outstanding common stock had been tendered as of 5:00 p.m. Eastern Time on Friday, February 3, 2006.